Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ITF Labomed is a prominent Chilean pharmaceutical company and a key subsidiary of the international Italfarmaco Group. The company specializes in the development, manufacturing, and commercialization of a wide range of pharmaceutical products, with a strong focus on therapeutic areas such as gynecology, neurology, respiratory health, and dermatology. Operating a manufacturing facility in Santiago, ITF Labomed produces high-quality medications that adhere to Good Manufacturing Practices (GMP) for both the local and regional Latin American markets. The company leverages the global research and development capabilities of its parent company to introduce innovative treatments, including advanced therapies for rare diseases and established brands in women's health and iron supplementation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ITF-Labomed Farmaceutica.